Antiproliferative Therapies in the SFA

Learn how the biological environment, mechanical challenges and timing of disease progression impact treatment of the SFA and how antiproliferative therapies help reduce the risk of restenosis.

Dr. Jay Kokate discusses the challenges of treating the SFA